Pharmaceutical Technology

JUNE 5, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

pharmaphorum

NOVEMBER 2, 2020

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge technologies. This knowledge is critical in understanding how effective certain drugs might be in treating the virus. What’s on the horizon?

Vaccines 132

Vaccines Drug Development Diabetes Immunity 132

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

pharmaphorum

OCTOBER 28, 2020

Data defines modern therapeutics, but this is almost uniquely confined to the clinical trial stages of drug development. Identifying, recruiting, retaining and monitoring patients during this part of the cycle is estimated to cost pharma US$19 billion a year as companies seek to harvest patient experiences.

Vaccines 118

Vaccines Hospitals Pharmaceutical Companies Pharmaceutical Companies 118

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 115

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 115

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. Delivering value for patients doesn’t start and end in our R&D labs; actions can be implemented across all stages of the drug development lifecycle to encourage and embrace a pro-innovation environment.

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 114

Pharma Marketing Network

MAY 11, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

pharmaphorum

OCTOBER 12, 2022

“We founded Whitelab Genomics after realising the potential to use data, data science, and AI in a more systematic way to develop genomic therapies,” Del Bourgo says. Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines.

Immunity 104

Immunity Immunization Drug Development Vaccines 104

Pharmaceutical Technology

MARCH 9, 2023

110 innovations will shape the pharmaceutical industry According to GlobalData’s Technology Foresights, which plots the S-curve for the pharmaceutical industry using innovation intensity models built on over 756,000 patents, there are 110 innovation areas that will shape the future of the industry.

Hospitals 52

Hospitals Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

Pharmaceutical Technology

DECEMBER 9, 2022

M&A – Commended PRODUCT LAUNCHES – Commended RESEARCH AND DEVELOPMENT – Commende d. Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. HQ ADDRESS: Römerpark 2.

Vaccines 52

Vaccines Biosimilars Compounding Packaging 52

Pharmaceutical Technology

NOVEMBER 4, 2022

For the pharmaceutical industry, disorder in the supply chain can be catastrophic especially when it comes to life saving and sustaining drugs. Global shortages of critical drugs are a growing issue, as demonstrated by the recent challenges around cold chains for COVID vaccines. The CMO solution. Time to evolve.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

The Digital Apothecary

MAY 13, 2017

As a pharmacy educator, I love the history of drug development for instance, and in every discussion, I have with students, whether in the classroom or small groups, I like to frame our current understanding of what we are doing based on what we used to do.

Diabetes 130

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JULY 1, 2021

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm’s Tanja Dowe. The next decade is where it really starts to get interesting, as we see more and more ‘synbio’-enabled drugs enter clinical trials.

Drug Development 88

Drug Development Pharmaceutical Companies Pharmaceutical Companies Vaccines 88

pharmaphorum

SEPTEMBER 9, 2021

The aim is to work with start-up companies to generate ideas for digital therapeutics, patient support apps, and boosting research and development. COVID-19 also put global supply chains in the spotlight, as industry looked to remove obstacles and speed the delivery of material crucial to vaccine development processes.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Immunity Immunization 64

Pharmaceutical Technology

DECEMBER 22, 2022

The company is a clinical-stage biopharmaceutical startup that uses its artificial intelligence (AI)-enabled platform to measure brain biomarkers, including electroencephalogram (EEG) activity and behavioural patterns, wearable data, genetics and other factors, to drive targeted drug development in mental health.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

AUGUST 26, 2008

It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals. As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 52

PharmaShots

FEBRUARY 21, 2023

The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y). Perseus has been discussing the collaborative development of PPMX-T002 with various RI medical drug-developing companies, including PeptiDream and its subsidiary PDRAdhiopharma.

Dosage 56

Dosage Labelling Immunity Immunization 56

European Pharmaceutical Review

JANUARY 16, 2023

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. The previous record for vaccine development and approval was four years for the measles vaccine.

Vaccines 125

Vaccines Research Laboratories Documentation Compounding 125

PharmaShots

FEBRUARY 20, 2023

After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 40

Pharmaceutical Technology

SEPTEMBER 26, 2022

GlobalData’s Contract Service Provider database shows that Novartis has 25 manufacturing sites in the US, Europe and China, including five API biologics (cell, gene, vaccine and virus) facilities in the US, France and Switzerland. These highlight the parent company’s focus on innovative and high-value drug development.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

pharmaphorum

FEBRUARY 16, 2021

President Joe Biden asked Slaoui to step down as chief scientific adviser to the US COVID-19 vaccine initiative after the White House administration changed late last month and the former GlaxoSmithKline research chief wasted no time in finding a new project.

Vaccines 58

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 58

pharmaphorum

MARCH 30, 2021

“There’s a lot that drug development for more common diseases could learn from rare disease R&D”. I think there’s a lot that drug development for more common diseases could learn from rare disease R&D.”. We have to be innovative to get around those challenges. Rare diseases during COVID.

Hospitals 110

Hospitals Communication Drug Development Pharmaceutical Companies 110

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. ” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “For certain cancers, yes,” says Ando.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 52

Pharmaceutical Technology

APRIL 12, 2023

The Association of the British Pharmaceutical Industry (ABPI) also states that “the use of animals in medical research has played and continues to play an essential role in the development of new medicines and vaccines”. The topic of animal testing remains a fiercely contentious topic in the public eye.

Vaccines 98

Vaccines Biosimilars Communication Pharmaceutical Companies 98

Pharmaceutical Technology

FEBRUARY 20, 2023

We are delighted to deepen our partnership with Teddy Lab that will enable us to build on existing knowledge and increase services within China to support customers with their global drug development programmes. About Teddy Clinical Research Laboratory : As a joint venture company established in 2016 by Dian Diagnostics (300244.SZ)

Research Laboratories 52

Research Laboratories Drug Development Vaccines Communication 52

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52